Suchergebnisse - "Bergmann, Lothar"

PubPharm (130)

1

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma : Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Motzer, R. | Porta, C. | Eto, M. | +134

2

Sunitinib for metastatic renal cell carcinoma : Real world data from the STAR-TOR registry and detailed literature review

enthalten in: Urologia internationalis | 2024

von Uhlig, A. | Bergmann, L. | Bögemann, M. | +10

3

Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma : A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass)

enthalten in: European urology | 2023

von Grünwald, V. | Ivanyi, P. | Zschäbitz, S. | +22

4

Nivolumab switch maintenance therapy after tyrosine kinase inhibitor induction in metastatic renal cell carcinoma : a randomized clinical trial by the interdisciplinary working group on renal tumors of the German cancer society (NIVOSWITCH; AIO-NZK-0116ass)

enthalten in: European urology | December 2023

von Grünwald, V. | Ivanyi, P. | Zschäbitz, S. | +22

5

Interdisciplinary recommendations for the treatment of advanced renal cell carcinoma

enthalten in: Aktuelle Urologie | 2022

von Miller, K. | Bergmann, L. | Doehn, C. | +4

6

A Prospectivly Randomized Phase-II Trial of Axitinib versus Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma (BERAT Study)

enthalten in: Oncology research and treatment | 2022

von Grünwald, V. | Hilser, T. | Meiler, J. | +6

7

Pathology and systemic therapy of non-clear cell renal cell carcinoma : an overview

enthalten in: Expert review of anticancer therapy | 2021

von Bergmann, L. | Weber, S. | Hartmann, A. | +1

8

Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors : the STAR-TOR registry

enthalten in: Future oncology (London, England) | 2021

von Strauss, A. | Schmid, M. | Rink, M. | +6

9

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

enthalten in: The New England journal of medicine | 2021

von Motzer, R. | Alekseev, B. | Rha, S. | +136

CommentIn: N Engl J Med. 2021 Apr 8;384(14):1360-1361. - PMID 33616313

10

Interdisciplinary recommendations for the treatment of advanced metastatic renal cell carcinoma

enthalten in: Aktuelle Urologie | 2020

von Miller, K. | Bergmann, L. | Doehn, C. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]